These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 19102391

  • 1. Effective treatment for advanced hepatocellular carcinoma with portal venous invasion using a combination therapy of intra-arterial 5-fluorouracil and subcutaneous pegylated-interferon-alpha-2b.
    Mawatari H, Kirikoshi H, Yoneda M, Higurashi T, Fujita K, Saito S, Inamori M, Takahashi H, Abe Y, Kubota K, Nakajima A.
    Hepatogastroenterology; 2008; 55(86-87):1776-7. PubMed ID: 19102391
    [Abstract] [Full Text] [Related]

  • 2. Therapeutic efficacy of combination therapy with intra-arterial 5-fluorouracil and systemic pegylated interferon α-2b for advanced hepatocellular carcinoma with portal venous invasion.
    Kasai K, Ushio A, Kasai Y, Sawara K, Miyamoto Y, Oikawa K, Kuroda H, Takikawa Y, Suzuki K.
    Cancer; 2012 Jul 01; 118(13):3302-10. PubMed ID: 22072099
    [Abstract] [Full Text] [Related]

  • 3. Arterial infusion of 5-fluorouracil combined with subcutaneous injection of pegylated interferon alpha-2b in treating unresectable hepatocellular carcinoma with portal vein tumor thrombus.
    Wu J, Huang WJ, Wang HY, Wang YF, Peng BG, Zhou Q.
    Med Oncol; 2015 Mar 01; 32(3):65. PubMed ID: 25691293
    [Abstract] [Full Text] [Related]

  • 4. Combined intraarterial 5-fluorouracil and intramuscular interferon-alpha therapy for advanced hepatocellular carcinoma.
    Ohmoto K, Iguchi Y, Mimura N, Tsuduki M, Shimabara M, Kuboki M, Yamamoto S.
    Hepatogastroenterology; 2003 Mar 01; 50(54):1780-2. PubMed ID: 14696403
    [Abstract] [Full Text] [Related]

  • 5. Hepatic arterial infusion of 5-fluorouracil in combination with subcutaneous interferon-alpha for advanced hepatocellular carcinoma.
    Kuroda M, Kobayashi Y, Urawa N, Yamamoto M, Mifuji R, Araki J, Tanaka H, Horiike S, Itani T, Furjita N, Konishi M, Iwasa M, Kaito M, Adachi Y.
    Hepatogastroenterology; 2007 Mar 01; 54(74):518-21. PubMed ID: 17523311
    [Abstract] [Full Text] [Related]

  • 6. Combined intraarterial 5-fluorouracil and subcutaneous interferon-alpha therapy for advanced hepatocellular carcinoma with tumor thrombi in the major portal branches.
    Sakon M, Nagano H, Dono K, Nakamori S, Umeshita K, Yamada A, Kawata S, Imai Y, Iijima S, Monden M.
    Cancer; 2002 Jan 15; 94(2):435-42. PubMed ID: 11900229
    [Abstract] [Full Text] [Related]

  • 7. [Development and research of the new therapy for hepatocellular carcinoma--combined interferon and 5-fluorouracil therapy].
    Nagano H, Sakon M, Monden M.
    Nihon Rinsho; 2002 Nov 15; 60(11):2237-44. PubMed ID: 12440136
    [Abstract] [Full Text] [Related]

  • 8. Interstitial pneumonia induced by combined intraarterial 5-fluorouracil and subcutaneous interferon-alpha therapy for advanced hepatocellular carcinoma.
    Yamamoto S, Tomita Y, Hoshida Y, Iizuka N, Marubashi S, Miyamoto A, Nagano H, Dono K, Umeshita K, Nakamori S, Sakon M, Aozasa K, Monden M.
    J Gastroenterol; 2004 Aug 15; 39(8):793-7. PubMed ID: 15338375
    [Abstract] [Full Text] [Related]

  • 9. Successful treatment of multiple hepatocellular carcinoma with tumor thrombi in the major portal branches by intraarterial 5-fluorouracil perfusion chemotherapy combined with subcutaneous interferon-alpha and hepatectomy.
    Yamamoto T, Nagano H, Imai Y, Fukuda K, Matsumoto H, Kondo M, Ota H, Nakamura M, Wada H, Noda T, Damdinsuren B, Dono K, Umeshita K, Nakamori S, Sakon M, Wakasa K, Monden M.
    Int J Clin Oncol; 2007 Apr 15; 12(2):150-4. PubMed ID: 17443284
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Combination therapy of intra-arterial 5-fluorouracil and systemic pegylated interferon α-2b for advanced hepatocellular carcinoma.
    Kasai K, Ushio A, Kasai Y, Sawara K, Miyamoto Y, Oikawa K, Kuroda H, Takikawa Y, Suzuki K.
    Int J Clin Oncol; 2011 Jun 15; 16(3):221-9. PubMed ID: 21132451
    [Abstract] [Full Text] [Related]

  • 13. Similar effects of recombinant interferon-alpha-2b and natural interferon-alpha when combined with intra-arterial 5-fluorouracil for the treatment of advanced hepatocellular carcinoma.
    Uka K, Aikata H, Takaki S, Miki D, Jeong SC, Hiramatsu A, Kodama H, Shirakawa H, Kawakami Y, Takahashi S, Toyota N, Ito K, Chayama K.
    Liver Int; 2007 Nov 15; 27(9):1209-16. PubMed ID: 17919232
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [A case of combined hepatocellular and cholangiocarcinoma showing tumor growth and invasion to the diaphragm during interferon-alpha and 5-fluorouracil combined intra-arterial chemotherapy].
    Noda T, Nagano H, Marubashi S, Kobayashi S, Takeda Y, Murakami M, Tomimaru Y, Dono K, Umeshita K, Nakayama M, Shima T, Wakasa K, Monden M, Doki Y, Mori M.
    Gan To Kagaku Ryoho; 2008 Nov 15; 35(12):2099-102. PubMed ID: 19106536
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.